Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN43633981
ISRCTN43633981
Completed
Not Applicable

Intrathecal Baclofen Infusion for Reflex sympathetic Dystrophy related dystonia

eiden University Medical Centre (LUMC) (The Netherlands)0 sites45 target enrollmentFebruary 26, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsReflex sympathetic dystrophy (RSD)Signs and SymptomsPain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Reflex sympathetic dystrophy (RSD)
Sponsor
eiden University Medical Centre (LUMC) (The Netherlands)
Enrollment
45
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 26, 2007
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
eiden University Medical Centre (LUMC) (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • •1\. All patients should fulfill the diagnostic criteria of the complex regional pain syndrome consensus report of the International Association for the Study of Pain (IASP):
  • •1\.1\. Continuing pain, allodynia or hyperalgesia, in which the pain is disproportionate to any inciting event
  • •1\.2\. Evidence at some time of oedema, changes in skin blood flow, or abnormal sudomotor activity in the region of the pain
  • •1\.3\. No condition that would otherwise account for the degree of pain and dysfunction
  • •2\. All patients must suffer from tonic dystonia in one or more extremities, that may cause fixed postures at rest of variable severity
  • •3\. Before starting the study all patients will have received a trial with oral baclofen. Only patients with an insufficient response or dose\-limiting sedative effects to oral baclofen are eligible for this study

Exclusion Criteria

  • •Does not comply with the above inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Phase 4
Intrathecal Baclofen therapy with the implanted pump system for Spastic Palsy (Post-marketing clinical trial extended phase 3 after NDA approval)[Spinal cord Origin] Spinal cord Injury, Multiple sclerosis, Spinocerebellar degeneration, Circulatory disorder of the spinal, Ossification of the posterior longitudinal ligament [Cerebral Origin] Cerebral palsy, Traumatic head injury
JPRN-jRCT1080220031DAIICHI SANKYO COMPANY, LIMITED
Completed
Not Applicable
The BIRD study. Intrathecal Baclofen Infusion for Reflex Sympathetic Dystrophy related dystonia.Reflex sympathetic dystrophy (RSD) related dystonia.
NL-OMON27484eiden University Medical Centre, Dept. of Neurology45
Not yet recruiting
Not Applicable
Intrathecal baclofen therapy for management of spasticity: An Australian paediatric multicentre prospective audit.Cerebral PalsySpinal Cord InjuryNeurological - Other neurological disorders
ACTRN12610000323022Princess Margaret Hospital for Children100
Active, not recruiting
Phase 1
Baclofen pump treatment for people with dystonic cerebral palsy: a comparison of placebo and baclofedytonic cerebral palsyMedDRA version: 19.1Level: PTClassification code 10008129Term: Cerebral palsySystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
EUCTR2010-019768-35-NL
Completed
Not Applicable
Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial
NL-OMON45097Vrije Universiteit Medisch Centrum41